INSIGHTS ON QUALITY ASSURANCE

• Pharma's Guide To Navigating Complex Impurity Compliance And Profiling

  Evolving regulations require proactive impurity control using trace‑level detection, solid risk assessment, advanced analytics, and ongoing monitoring to prevent compliance issues.

• Building Training Programs And User Controls That Last Beyond Go-Live

  Validation success doesn’t guarantee audit readiness. When training fades, compliance risk grows quietly. Learn how post-go-live gaps surface and how programs prevent findings before auditors do.

• Select The Best Analyte: A Guide To Effective Mycoplasma Testing

  As you build a Mycoplasma testing strategy to ensure drug safety, there are three analyte types to choose from: live Mycoplasma, RNA, and genomic DNA, each offering distinct advantages.

• Doubling Up For Speed In Biomanufacturing

  Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

• Operational Readiness Frameworks For Pharma And Biotech

  11/14/2025

  Achieving top performance in life sciences requires a continuous journey from Operational Readiness (OR) to sustained Operational Excellence (OE), ensuring safe startup and long-term efficiency.

• How Automated NGS Solutions Advance Rare Disease Research

  2/27/2026

  See how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.

• Becton Dickinson: Enhancing Maintenance Compliance

  8/8/2025

  Learn how BD standardized calibration across 85 sites with a RAM to boost compliance, efficiency, and system integration for scalable, future-ready operations.

• Performance Dashboards Development

  7/22/2025

  Learn about a biotech company's successful implementation of a two-level KPI dashboard system. This enhanced performance monitoring, aligned departmental goals, and strengthened team communication.

• FDA's CSA Guidance Is Final: What It Means For Your Validation Strategy

  3/23/2026

  Understand the FDA's shift from rigid CSV to risk-based software assurance. Binary risk classification and flexible testing approaches reduce validation timelines for production and quality.